Imaging asparaginyl endopeptidase (AEP) in the live brain as a biomarker for Alzheimer’s disease

BACKGROUND: Discovery of early-stage biomarkers is a long-sought goal of Alzheimer’s disease (AD) diagnosis. Age is the greatest risk factor for most AD and accumulating evidence suggests that age-dependent elevation of asparaginyl endopeptidase (AEP) in the brain may represent a new biological mark...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shan-Shan, Liu, Zi-Kai, Liu, Jing-Jing, Cheng, Qing, Wang, Yan-Xia, Liu, Yan, Ni, Wen-Wen, Chen, Hong-Zhuan, Song, Mingke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375181/
https://www.ncbi.nlm.nih.gov/pubmed/34412639
http://dx.doi.org/10.1186/s12951-021-00988-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375181/
https://www.ncbi.nlm.nih.gov/pubmed/34412639
http://dx.doi.org/10.1186/s12951-021-00988-0

Ejemplares similares